No Data
Insider Sale: CEO Jon Congleton Sells Shares of Mineralys Therapeutics Inc (MLYS)
Mineralys Therapeutics(MLYS.US) Officer Sells US$592.02K in Common Stock
$Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon sold 49,313 shares of common stock on Jun 17, 18, 20, 2024 at an average price of $12.0054 for a total value of $592.02K.Source: Announcement Wh
Mineralys Therapeutics Insider Sold Shares Worth $592,022, According to a Recent SEC Filing
Jon Congleton, Director, Chief Executive Officer, on June 17, 2024, sold 49,313 shares in Mineralys Therapeutics (MLYS) for $592,022. Following the Form 4 filing with the SEC, Congleton has control ov
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 175.24K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 20, $Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon intends to sell 14,940 shares of its common stock on Jun 20, with a total market value of approximately $175.24K
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 199.07K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 18, $Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon intends to sell 16,607 shares of its common stock on Jun 18, with a total market value of approximately $199.07K
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 217.71K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon intends to sell 17,766 shares of its common stock on Jun 17, with a total market value of approximately $217.71K